Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment (2007)
- Authors:
- USP affiliated authors: FANELLI, CAMILLA - FM ; FERNANDES, BIANCA HELENA VENTURA - FM ; FUJIHARA, CLARICE KAZUE - FM
- Unidade: FM
- Subjects: NEFROPATIAS (INDUZIDO QUIMICAMENTE); MEDICAMENTO (EFEITOS ADVERSOS); RESUMOS (SIMPÓSIOS)
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio avanços em pesquisas médicas
-
ABNT
FANELLI, Camilla et al. Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 30 abr. 2024. , 2007 -
APA
Fanelli, C., Fernandes, B. H. V., Machado, F. G., Poppi, E. P. B., Malheiros, D. M. A. C., Fujihara, C. K., & Zatz, R. (2007). Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Fanelli C, Fernandes BHV, Machado FG, Poppi EPB, Malheiros DMAC, Fujihara CK, Zatz R. Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment. Clinics. 2007 ; 62 S48.[citado 2024 abr. 30 ] -
Vancouver
Fanelli C, Fernandes BHV, Machado FG, Poppi EPB, Malheiros DMAC, Fujihara CK, Zatz R. Combined losartan and hydrochlorothiazide prevents progression of renal injury in chronic nephropathy resulting from losartan treatment. Clinics. 2007 ; 62 S48.[citado 2024 abr. 30 ] - Regression of diabetic nephropathy: no dose-response effect of an angiotensin II antagonist
- High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac)
- Combined Losartan (L) and Hydrocholorothyazide (H) treatment (LH) prevents progression of chronic kidney disease (CKD) resulting from L treatment during lactation (LLac)
- Regressão da nefropatia diabética experimental: Ausência de efeito dose resposta de um antagonista da angiotensina II
- Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload
- Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX)
- Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model
- Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD)
- Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure
- Associação terapêutica de losartan (L) e hidroclorotiazida (H) previne progressão da lesão renal em modelo de nefropatia crônica resultante da administração de (L) durante a lactação
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
